179 related articles for article (PubMed ID: 7010166)
1. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin substitution for heparin in long-term hemodialysis.
Smith MC; Danviriyasup K; Crow JW; Cato AE; Park GD; Hassid A; Dunn MJ
Am J Med; 1982 Nov; 73(5):669-78. PubMed ID: 6753575
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
Kuźniewski M; Sułowicz W
Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin and heparin during haemodialysis: comparative effects.
Camici M; Evangelisti L
Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
[TBL] [Abstract][Full Text] [Related]
5. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis.
Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH
Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
Rådegran K; Arén C; Teger-Nilsson AC
J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
[TBL] [Abstract][Full Text] [Related]
7. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
[TBL] [Abstract][Full Text] [Related]
8. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
9. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
Gainza FJ; Quintanilla N; Pijoan JI; Delgado S; Urbizu JM; Lampreabe I
J Nephrol; 2006; 19(5):648-55. PubMed ID: 17136695
[TBL] [Abstract][Full Text] [Related]
10. Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure.
Fiaccadori E; Maggiore U; Parenti E; Giacosa R; Picetti E; Rotelli C; Tagliavini D; Cabassi A
Nephrol Dial Transplant; 2007 Feb; 22(2):529-37. PubMed ID: 17071958
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
[TBL] [Abstract][Full Text] [Related]
12. Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent.
Fiaccadori E; Maggiore U; Rotelli C; Minari M; Melfa L; Cappè G; Cabassi A
Intensive Care Med; 2002 May; 28(5):586-93. PubMed ID: 12029407
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin.
Camici M; Giordani R; Morelli E; Meriggioli M; Balestri PL; Barsotti G; Sagripanti A
Minerva Med; 1998; 89(11-12):405-9. PubMed ID: 10212664
[TBL] [Abstract][Full Text] [Related]
14. Heparin and prostacyclin.
Camici M; Evangelisti L
Angiology; 1989 Apr; 40(4 Pt 1):294-9. PubMed ID: 2650580
[TBL] [Abstract][Full Text] [Related]
15. Haemodialysis without heparin.
Woods HF; Weston MJ; Bunting S
Proc Eur Dial Transplant Assoc; 1978; 15():122-9. PubMed ID: 368769
[TBL] [Abstract][Full Text] [Related]
16. [Lipid behavior during hemodialysis using heparin and prostacyclin].
Camici M; Evangelisti L
Minerva Med; 1992 Dec; 83(12):801-4. PubMed ID: 1491759
[TBL] [Abstract][Full Text] [Related]
17. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
Maurin N; Ballmann M
Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
[TBL] [Abstract][Full Text] [Related]
18. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications.
Swartz RD; Flamenbaum W; Dubrow A; Hall JC; Crow JW; Cato A
J Clin Pharmacol; 1988 Sep; 28(9):818-25. PubMed ID: 3068260
[TBL] [Abstract][Full Text] [Related]
19. The effect of prostacyclin on intracranial pressure in patients with acute hepatic and renal failure.
Davenport A; Will EJ; Davison AM
Clin Nephrol; 1991 Apr; 35(4):151-7. PubMed ID: 1855317
[TBL] [Abstract][Full Text] [Related]
20. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
